RTICC International Guest Seminar- Prof. David Avigan, MD

Prof. David Avigan, M.D
Director, Cancer Center
Beth Israel Deaconess Medical Center
Harvard Medical School, USA

“Looking towards the next generation of cancer vaccines"

I will be discussing a personalized approach to developing cancer vaccines that allows for the targeting of neoantigens and integration with the rapidly evolving field of cellular immunotherapy. Leveraging innate and adaptive immunity to eliminate cancer.

The RTICC aspires to become a leading center, attracting top-tier researchers renowned both nationally and internationally for their contributions to cancer research in various fields.
A key objective is to foster collaborations and engage with leading scientists, all with the aim of advancing cancer treatment and improving patient outcomes. Therefore, we host the RTICC International Guest Seminar, which is delivered by acclaimed expert academic speakers.